<?xml version="1.0" encoding="UTF-8"?>
<p>Other therapeutic options, with lower chances of success—according to the WHO—are monoclonal or polyclonal antibodies, or serum collected from patients with SARS-COV-2, which contains antibodies against infection (
 <xref rid="B25" ref-type="bibr">25</xref>). However, a study involving plasma harvested from patients cured of SARS-COV-2 and its administration in severe cases of pulmonary disease has been initiated—in which a few cases of clinical remission have been described (
 <xref rid="B81" ref-type="bibr">81</xref>).
</p>
